awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47967056-24E000BB-99C8-4465-8D02-18093A17DCA7
Q47967056-24E000BB-99C8-4465-8D02-18093A17DCA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47967056-24E000BB-99C8-4465-8D02-18093A17DCA7
Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
P2860
Q47967056-24E000BB-99C8-4465-8D02-18093A17DCA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47967056-24E000BB-99C8-4465-8D02-18093A17DCA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8c7c019520c422a7bc89216c33bc9a9922f3b0b0
P2860
Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.